Sign up to save your podcasts
Or
Share Morgans Under the Microscope
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Morgans Under the Microscope episodes
- Under the microscope: Weekly Wrap Week Ending 31 July 2020Morgans analyst Iain Wilkie runs through a number of healthcare stocks reporting quarterly statements over the week as well as a broader market wrap.7 min
- Under the microscope: Weekly Wrap Week Ending 10 July 2020Morgans Analyst Iain Wilkie provides an update on the healthcare market and discusses a some significant swings in a number of micro-cap stocks and highlights two stocks worth watching for the upcoming cashflow reporting season this month.6 min
- Under the microscope: Mach7 Technologies (ASX:M7T) - Scott Power, Senior AnalystMorgans Healthcare Analyst Scott Power provides an update on Mach 7 (M7T) following their successful capital raising.4 min
- Under the microscope: Cochlear (ASX:COH) - Derek Jellinek, Senior AnalystCochlear (COH) gains FDA’s blessing on multiple products, but nothing appears game-changing.6 min
- Under the microscope: Imagion Biosystems (ASX:IBX) - Robert Proulx, Chief Executive OfficerBob Proulx CEO of Imagion Biosystems (IBX) provides an update on the company’s progress after it announced plans to start human studies using its MagSense technology.7 min
- Under the microscope: Regeneus (ASX:RGS) - Iain Wilkie, AnalystMorgans Analyst Iain Wilkie talks to CEO of ASX listed regenerative medicine and stem-cell player Regeneus (ASX:RGS) on what the company does and a number of potential catalysts which lie ahead.11 min
- Under the microscope: ResApp Health (ASX:RAP) - Tony Keating, Managing Director & CEOResApp Health (RAP) CEO Tony Keating provides an update on the progression of commercialisation of its diagnostic into the telehealth setting, an update on the SleepCheck product, and outlines a number of key drivers ahead.9 min
- Under the microscope: Weekly Wrap Week Ending 5 June 2020Healthcare analyst Iain Wilkie gives another market update and runs through a number of small cap healthcare announcements over the week.6 min
- Under the microscope: Healthcare Update - Scott Power, Senior AnalystScott Power provides comments on CSL, Sonic, Promedicus, Nanosonics and Volpara.5 min
- Under the microscope: Neuren Pharmaceuticals (ASX:NEU) - Jon Pilcher, Chief Executive OfficerJon Pilcher CEO of Neuren Pharmaceuticals provides an update on the clinical trials the company is undertaking.5 min
About Morgans Under the Microscope
From the publisher's feed
A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.